Business
The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
- 416 episodes
- Updated Thursday
Episodes416
Aug 15, 2019 · 29 min
Aug 8, 2019 · 19 minEpisode 74: Novartis and the no good, very bad week
Aug 1, 2019 · 23 minEpisode 73: Canadian pills, corporate jets, & racists with spit kits
Jul 25, 2019 · 26 minEpisode 72: Vertex's regime change, the return of Ebola, & the rise of digital health
Jul 18, 2019 · 25 minEpisode 71: Elon Musk's monkey cyborg, Gilead's shifting future, & an app for anxiety
Jul 11, 2019 · 29 minEpisode 70: A whirlwind week in Washington, Sean Parker's mansion, & remembering a voice in biotech
Jun 27, 2019 · 25 minEpisode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
Jun 20, 2019 · 26 minEpisode 68: A controversial desire drug, courtroom genealogy, & the quest for longer life
Jun 13, 2019 · 25 minEpisode 67: Biohacking meets bureaucracy, and the latest twist in CRISPR world
Jun 6, 2019 · 26 minEpisode 66: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party
Jun 4, 2019 · 29 minEpisode 65: A special episode from the halls of the ASCO meeting
May 30, 2019 · 23 minEpisode 64: Feuding professors, failing businesses, and journalism 101
May 23, 2019 · 31 minEpisode 63: Your ASCO preview, genetic whiplash, and a journalist's experience with cancer
May 16, 2019 · 23 minEpisode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials
May 9, 2019 · 25 minEpisode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA
May 2, 2019 · 22 minEpisode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms
Apr 25, 2019 · 22 minEpisode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup
Apr 18, 2019 · 21 minEpisode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print
Apr 11, 2019 · 25 minEpisode 57: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst
Apr 4, 2019 · 28 minEpisode 56: Cheaper insulin, the next Juul, and diagnosing disease with sound